Search - tctmd.com

Displaying 1 - 20 of 571

Sort: Relevancy | Date

Presentation TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Presenter: Patrick W. Serruys

October 28, 2025

Presentation TCT 2025

TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions

Presenter: Eun-Seok Shin

October 28, 2025

Presentation TCT 2025

TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective

Presenter: Kyung-Taek Park

October 28, 2025

Presentation TCT 2025

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

Presenter: Robert-Jan Van Geuns

October 28, 2025

Presentation TCT 2025

TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome

Presenter: Hisaki Masuda

October 28, 2025

Presentation TCT 2025

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

Presenter: Bo Song

October 28, 2025

Presentation TCT 2025

TCT 1654: Coronary Pseudoaneurysm due to Drug Eluting Stent

Presenter: Saroj Kumar Sahoo

October 28, 2025

Presentation TCT 2025

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

Presenter: Yuko Kiyohara

October 27, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Presentation TCT 2025

TCT 592: INTRAVASCULAR ULTRASOUND-GUIDED DRUG ELUTING STENTING FOR RENAL ARTERY STENOSIS: SINGLE CENTER PILOT STUDY 2017-2023

Presenter: Muhammad Haisum Maqsood

October 27, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

Presenter: Terumitsu Hasebe

October 27, 2025

Presentation TCT 2025

TCT 95: IVUS-Guided Drug-Eluting Stent Implantation in Patients With Coronary Artery Disease and Chronic Kidney Disease

Presenter: Xiaofei Gao

October 27, 2025

Presentation TCT 2025

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

Presenter: Kamil Bujak

October 27, 2025

Presentation TCT 2025

TCT 508: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Large Coronary Artery Disease: A Systematic Review and Meta-analysis.

Presenter: Mohamed Elnady

October 27, 2025

Presentation TCT 2025

TCT 509: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Small Coronary Artery Disease: A Systematic Review and Meta-Analysis

Presenter: Mohamed Elnady

October 27, 2025

Presentation TCT 2025

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

Presenter: Yuehao Lv

October 27, 2025

Presentation TCT 2025

TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial

Presenter: Ping Wang

October 27, 2025

Presentation TCT 2025

TCT 504: Comparison of Drug Coated Balloon versus Drugs Eluting Stent Angioplasty in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Presenter: Kyriakos Dimitriadis

October 27, 2025

Presentation TCT 2025

TCT 505: Long-Term Efficacy of Drug Coated Balloon versus Drug Eluting Stent Angioplasty in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Presenter: Kyriakos Dimitriadis

October 27, 2025

Advertisement

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

TCT 513: Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Single De Novo Diffuse Coronary Lesions

TCT 963: Ethnic Disparities in Inflammatory Phenotype and CV Outcomes After Drug-Eluting Stent Implantation: A Multiethnic Perspective

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

TCT 619: Validation of Novel Endpoint for Optimal Drug-eluting stent Implantation in Patients with Acute Coronary Syndrome

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

TCT 1654: Coronary Pseudoaneurysm due to Drug Eluting Stent

TCT 468: Comparison of Limus and Paclitaxel Drug-Coated Balloons, 2nd-generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

TCT 592: INTRAVASCULAR ULTRASOUND-GUIDED DRUG ELUTING STENTING FOR RENAL ARTERY STENOSIS: SINGLE CENTER PILOT STUDY 2017-2023

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

TCT 95: IVUS-Guided Drug-Eluting Stent Implantation in Patients With Coronary Artery Disease and Chronic Kidney Disease

TCT 511: Paclitaxel-Coated Balloons versus Newer-Generation Drug-Eluting Stents for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Controlled Trials

TCT 508: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Large Coronary Artery Disease: A Systematic Review and Meta-analysis.

TCT 509: Drug-Coated Balloon Versus Drug-Eluting Stent in De Novo Small Coronary Artery Disease: A Systematic Review and Meta-Analysis

TCT 502: Drug-Coated Balloons Versus Drug-Eluting Stents for Patients with Diffuse De Novo Coronary Artery Lesions: Insights from the REC-CAGEFREE I Trial

TCT 503: Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial

TCT 504: Comparison of Drug Coated Balloon versus Drugs Eluting Stent Angioplasty in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

TCT 505: Long-Term Efficacy of Drug Coated Balloon versus Drug Eluting Stent Angioplasty in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content